| (2019). Prolactin receptor binding proteins and uses thereof. Patent Number: IL239502B. |
|
Patent |
|
| (2021). Methods for improving response to anti-lif antibody treatment in individuals with cancer. Patent Number: IL279484A. |
|
Patent |
|
| (2023). CORE/CASING ENGINEERING WITH GAPS (CSVE) OF CATALYST FOR ELECTROCHEMICAL CO2 REDUCTION. Patent Number: PT3791010T. |
|
Patent |
|
| (2020). Combination of lif inhibitors and pd-1 axis inhibitors for use in treating cancer. Patent Number: IL277918A. |
|
Patent |
|
| (2021). Combination of lif inhibitors and platinum-based antineoplastic agents for use in treating cancer. Patent Number: IL279444A. |
|
Patent |
|
| (2021). ANTIBODY. Patent Number: PT3311170T. |
|
Patent |
|
| (2022). Surgical method for treatment of auditory disease or condition. Patent Number: GB202213060D0. |
|
Patent |
|
| (2023). Antibodies to tigit. Patent Number: IL298111A. |
|
Patent |
|
| (2023). ANTI-BCMA ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND BCMA AND CD3, AND USES THEREOF. Patent Number: CY2023007I2. |
|
Patent |
|
| (2023). teclistamab. Patent Number: NL301219I2. |
|
Patent |
|
| (2023). ANTI-BCMA ANTIBODIES, BCMA AND CD3-BINDING BISPECIFIC ANTIGEN-BINDING MOLECULES AND USES THEREOF. Patent Number: FR23C1011I1. |
|
Patent |
|
| (2022). Nanoparticle platform for antibody and vaccine delivery. Patent Number: PT3661968T. |
|
Patent |
|
| (2021). MODELING TEST. Patent Number: PT3311169T. |
|
Patent |
|
| (2023). Anti-bcma antibodies, bispecific antigen binding molecules that bind bcma and cd3, and uses thereof. Patent Number: IL257468B2. |
|
Patent |
|
| (2021). Stable heterodimeric antibody design with mutations in the fc domain. Patent Number: PT2773671T. |
|
Patent |
|